Stephen Gottschalk, MD, on CAR T Cells for Solid Tumors: What Are the Challenges?

2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Tweet this page

Stephen Gottschalk, MD, of Baylor College of Medicine and Texas Children’s Hospital, discusses combining CAR T cells with checkpoint blockade or targeted treatments to improve their antitumor activity in solid tumors.

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.